Retatrutide is not FDA-approved and does not have a standard prescription pathway
Disclaimer: Reference ranges may vary by laboratory
Even if the peptide is eventually returned to the freezer or refrigerator, extended exposure to higher temperatures causes gradual degradation
It is a fixed-dose combination of sitagliptin and metformin XR for adults with type 2 diabetes
Small volume: Ideal for subcutaneous injections of small volumes (0.3 to 1.0 ml)
Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery dehydration leading to kidney problems